PCSK9 inhibition with alirocumab in pediatric patients with heterozygous familial hypercholesterolemia: The ODYSSEY KIDS study. (Record no. 30898126)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01567 a2200445 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250518100618.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 202108s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1933-2874 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1016/j.jacl.2020.03.001 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Daniels, Stephen |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20210806 |
245 00 - TITLE STATEMENT | |
Title | PCSK9 inhibition with alirocumab in pediatric patients with heterozygous familial hypercholesterolemia: The ODYSSEY KIDS study. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Journal of clinical lipidology |
Date of publication, distribution, etc. | |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 322-330.e5 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Adolescent |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antibodies, Monoclonal, Humanized |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Anticholesteremic Agents |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Child |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Double-Blind Method |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Heterozygote |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Hyperlipoproteinemia Type II |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Male |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Middle Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | PCSK9 Inhibitors |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Treatment Outcome |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Caprio, Sonia |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Chaudhari, Umesh |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Manvelian, Garen |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Baccara-Dinet, Marie T |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Brunet, Aurelie |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Scemama, Michel |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Loizeau, Virginie |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Bruckert, Eric |
773 0# - HOST ITEM ENTRY | |
Title | Journal of clinical lipidology |
Related parts | vol. 14 |
-- | no. 3 |
-- | p. 322-330.e5 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1016/j.jacl.2020.03.001">https://doi.org/10.1016/j.jacl.2020.03.001</a> |
Public note | Available from publisher's website |
No items available.